Ledifos Ledipasvir Tablet

Ledifos Ledipasvir Tablet Specification

Brand Name
Ledifos

Salt Composition
Ledipasvir and Sofosbuvir

Life Span
2 years from manufacturing date

Pacakaging (Quantity Per Box)
28 Tablets

Dosage Form
Film-coated tablet

Origin of Medicine
India

Indication
Treatment of HCV genotype 1, 4, 5, and 6 infection

Packaging Type
Plastic bottle

Drug Type
Allopathic

Ingredients
Ledipasvir 90 mg, Sofosbuvir 400 mg

Physical Form
Tablets

Function
Antiviral medication

Recommended For
Chronic Hepatitis C infection

Dosage
As directed by physician

Dosage Guidelines
As per the doctor's advice

Suitable For
Adults

Quantity
28 tablets per bottle

Storage Instructions
Keep at cool and Dry Place

Side Effects
Fatigue, headache, nausea

Storage Condition
Room temperature, protected from excess heat

MRP
As per current regulations

Expiry Date
Printed on packaging

Colour
Yellow

Approval
Centrally approved by regulatory authorities

Minimum Order Quantity
1 bottle (28 tablets)

Contraindications
Hypersensitivity to ingredients, use with amiodarone

Route of Administration
Oral

Prescription Required
Yes

Therapeutic Area
Antiviral / Hepatology

Shape
Oval

Batch Number
Printed on packaging

Patient Age Group
18 years and above

Ledifos Ledipasvir Tablet Trade Information

Minimum Order Quantity
100 Bottles

Supply Ability
5000 Bottles Per Month

Delivery Time
7 Days

Main Export Market(s)
Asia, Australia, North America, Eastern Europe, Western Europe

About Ledifos Ledipasvir Tablet

Ledifos Ledipasvir Tablet is an in-demand, world-class antiviral solution recommended for adults battling chronic Hepatitis C. Combining Ledipasvir (90 mg) and Sofosbuvir (400 mg), this matchless, radiant yellow, oval tablet delivers exceptional efficacy for HCV genotypes 1, 4, 5, and 6. Each bottle contains 28 film-coated tablets, ensuring convenience for patients and healthcare providers. Centrally approved and trusted by professionals, Ledifos is highly popular among prescribers. Order today to benefit from its proven track record in hepatology. Prescription required. Minimum order: 1 bottle.

Comprehensive Application in Hepatology

Ledifos Ledipasvir Tablet is used for the treatment of chronic Hepatitis C infection, specifically targeting HCV genotypes 1, 4, 5, and 6. Its application falls under the antiviral and hepatology domain, providing world-class results for adult patients aged 18 and above. Administered orally with water, this film-coated tablet ensures easy consumption. Ledifos stands as a preferred choice due to its proven efficacy and radiance in combating chronic viral hepatitis.

Premium Supply and Export Excellence

Ledifos Ledipasvir Tablet supply is managed with great precision, ensuring each order is dispatched promptly for your convenience. Shipped via leading FOB ports in India, Ledifos reaches global markets efficiently. Our supply chain supports premium exports to Asia, Africa, the Middle East, and worldwide, reflecting its popularity among international medical providers. Secure your batch with confidence, as each package guarantees matchless quality and compliance with regulatory standards.

Specification

Form	Tablet
Packaging Type	Bottle
Packaging Size	28 Tablets
Prescription/Non prescription	Prescription
Treatment	Chronic Hepatitis C
Composition	Ledipasvir (90 mg) + Sofosbuvir (400 mg)

FAQ's of Ledifos Ledipasvir Tablet:

Q: How should Ledifos Ledipasvir Tablet be taken for best results?

A: Ledifos Ledipasvir Tablet should be taken orally as directed by a physician. Adhere to the prescribed dosage and duration for maximum effectiveness.

Q: What conditions is Ledifos Ledipasvir Tablet recommended to treat?

A: This medication is indicated for the treatment of chronic Hepatitis C infection, particularly for adults diagnosed with HCV genotypes 1, 4, 5, or 6.